Ocular Therapeutix COO James Fortune to leave, effective December 31
On October 13, Ocular Therapeutix entered into a transition, separation and release of claims agreement with James Fortune, pursuant to which Fortune has resigned from his role as COO and any and all other positions he holds as an officer or employee of the company, effective December 31, or such earlier date as may be mutually agreed upon by Fortune and the company. Pursuant to the Transition Agreement, effective as of the Agreement Effective Date, the Employment Agreement, by and between the company and Fortune, dated June 19, 2014, was terminated. From the Agreement Effective Date to the Separation Date, Fortune will continue to serve as COO and as an at-will employee of the company. In addition to his regular duties, Fortune will also perform such additional transition duties as may be requested by and at the direction of the company.